You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

nivolumab

Showing 51 - 75 of 806
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Mucinous Tumor, Colorectal Tumor, Appendiceal Tumor Trial in Philadelphia (Nivolumab, Ipilimumab)

Terminated
Has Results
  • Mucinous Adenocarcinoma of the Colon
  • Mucinous Adenocarcinoma of the Rectum
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Sep 26, 2022

Melanoma, Urothelial Carcinoma Trial in Berlin (Nivolumab/rHuPH20, Nivolumab)

Not yet recruiting
  • Melanoma
  • Urothelial Carcinoma
  • Berlin, Germany
    Local Institution - 0001
Aug 9, 2022

Advanced Cancer, Clear Cell Renal Cell Carcinoma Trial in Houston (177Lu girentuximab, Nivolumab, Cabozantinib)

Not yet recruiting
  • Advanced Cancer
  • Clear Cell Renal Cell Carcinoma
  • 177Lu girentuximab
  • +3 more
  • Houston, Texas
    MD Anderson Cancer Center
Dec 15, 2022

Clear Cell Renal Cell Carcinoma, Sarcomatoid Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8 Trial in Duarte

Recruiting
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Biospecimen Collection
  • +6 more
  • Duarte, California
    City of Hope Medical Center
Sep 19, 2023

Melanoma Stage III, Melanoma Stage IV, Inoperable Disease Trial in Tampa (Interleukin-2, Ipilimumab, Nivolumab)

Recruiting
  • Melanoma Stage III
  • +2 more
  • Tampa, Florida
    Moffitt Cancer Center
Dec 6, 2022

Bladder Cancer Trial in United States (Nivolumab, Nivolumab/Lirilumab)

Completed
Has Results
  • Bladder Cancer
  • Tampa, Florida
  • +7 more
Nov 4, 2022

Esophageal Cancer Trial in Rotterdam (Nivolumab)

Not yet recruiting
  • Esophageal Cancer
  • Nivolumab
  • Rotterdam, Netherlands
    Erasmus MC
Aug 4, 2022

Metastatic Melanoma, Skin Cancer Trial in Boston (Ipilimumab, Nivolumab, Cryoablation)

Not yet recruiting
  • Metastatic Melanoma
  • Skin Cancer
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Mar 9, 2023

Prostate Cancer Trial in Boston, South Weymouth, Londonderry (Nivolumab)

Recruiting
  • Prostate Cancer
  • Nivolumab
  • Boston, Massachusetts
  • +4 more
Dec 5, 2022

Classical Hodgkin Lymphoma Trial in Cologne (Nivolumab, Adriamycin, Vinblastine)

Active, not recruiting
  • Classical Hodgkin Lymphoma
  • Nivolumab
  • +3 more
  • Cologne, Germany
    University Hospital of Cologne
Aug 5, 2022

Hodgkin Lymphoma Trial in Moscow (Nivolumab)

Recruiting
  • Hodgkin Lymphoma
  • Nivolumab
  • Moscow, Russian Federation
    The Federal Budget-Funded Institution National Medical Surgical
Oct 31, 2022

Hodgkin Lymphoma, Relapsed Hodgkin's Disease, Adult, Refractory Hodgkin Lymphoma Trial in Boston (Nivolumab, Ipilimumab)

Recruiting
  • Hodgkin Lymphoma
  • +2 more
  • Boston, Massachusetts
  • +2 more
Oct 18, 2022

Pancreatic Cancer, Metastatic Pancreatic Cancer Trial in Boston (Nivolumab, Ipilimumab, Radiation)

Active, not recruiting
  • Pancreatic Cancer
  • Metastatic Pancreatic Cancer
  • Nivolumab
  • +2 more
  • Boston, Massachusetts
  • +2 more
Sep 7, 2022

Prostate Cancer, Prostate Disease Trial in Tampa (Nivolumab, Brachytherapy, External Beam Radiation Therapy)

Recruiting
  • Prostate Cancer
  • Prostate Disease
  • Nivolumab
  • +3 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Nov 11, 2022

Pituitary, Pituitary Tumor, Pituitary Carcinoma Trial in United States (Ipilimumab, Nivolumab)

Recruiting
  • Pituitary
  • +3 more
  • Los Angeles, California
  • +7 more
Oct 31, 2022

Effect of Drug Trial in Taichung (Nivolumab, all trans retinoic acid)

Completed
  • Effect of Drug
  • Nivolumab
  • all trans retinoic acid
  • Taichung, Please Select, Taiwan
    China Medical University Hospital
Jul 28, 2022

Hepatocellular Carcinoma, Hepatocellular Cancer, Metastatic Pancreatic Cancer Trial run by the NCI (nivolumab, tadalafil, oral

Completed
  • Hepatocellular Carcinoma
  • +4 more
  • nivolumab
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Triple Negative Breast Cancer Trial in Saint Louis (drug, biological, procedure)

Recruiting
  • Triple Negative Breast Cancer
  • Saint Louis, Missouri
    Washington University School of Medicine
Oct 19, 2022

Melanoma (Skin) Trial in Tampa (biological, drug, procedure)

Active, not recruiting
  • Melanoma (Skin)
  • NY-ESO-1 157-165 (165V)
  • +5 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jan 17, 2023

NSCLC Trial in Singapore (Ipilimumab, Nivolumab)

Terminated
  • Non-Small Cell Lung Cancer
  • Singapore, Singapore
  • +2 more
Jun 10, 2022

Metastatic Uveal Melanoma Trial in Miami (Nivolumab, Relatlimab)

Recruiting
  • Metastatic Uveal Melanoma
  • Miami, Florida
    University of Miami Sylvester Comprehensive Cancer Center
Aug 23, 2022

Biliary Tract Cancer Trial in Boston, Ann Arbor, Nashville (Rucaparib, Nivolumab)

Active, not recruiting
  • Biliary Tract Cancer
  • Boston, Massachusetts
  • +2 more
Dec 6, 2022

Advanced Solid Tumors, NSCLC Trial in Hackensack (BMS-986442, Nivolumab, Docetaxel)

Not yet recruiting
  • Advanced Solid Tumors
  • Non-small Cell Lung Cancer
  • BMS-986442
  • +5 more
  • Hackensack, New Jersey
    John Theurer Cancer Center at Hackensack University Medical Cent
Sep 14, 2022

Nasopharyngeal Carcinoma Trial (procedure, drug, biological)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • Biospecimen Collection
  • +9 more
  • (no location specified)
Sep 12, 2023

Ovarian Cancer Trial in Boston (drug, biological, procedure)

Recruiting
  • Ovarian Cancer
  • Nivolumab
  • +2 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jul 11, 2022